Latest filing published 29 Sept 2025 for Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.), €34k.
Menassie Mammo Taddese appears in our data through filings on Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.) shares, published by SEDI. In total, 4 filings cover trades dated from 6 February 2023 to 25 September 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 29 September 2025, reports an option exercise of €34k in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 4 days. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations